|
Volumn 61, Issue 5, 2013, Pages 533-535
|
Smoking cessation after acute myocardial infarction
|
Author keywords
acute myocardial infarction; bupropion; randomized controlled trial; smoking cessation
|
Indexed keywords
AMFEBUTAMONE;
NICOTINE;
PLACEBO;
VARENICLINE;
ACUTE CORONARY SYNDROME;
ACUTE HEART INFARCTION;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR MORTALITY;
CARDIOVASCULAR RISK;
CLINICAL EFFECTIVENESS;
CLINICAL TRIAL (TOPIC);
COMORBIDITY;
CORONARY ARTERY ATHEROSCLEROSIS;
CORONARY ARTERY CONSTRICTION;
DISEASE ASSOCIATION;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
DYSLIPIDEMIA;
ENDOTHELIAL DYSFUNCTION;
FAINTNESS;
FOLLOW UP;
HEART ARRHYTHMIA;
HEART GRAFT;
HEART GRAFT THROMBOSIS;
HEART INFARCTION;
HEART MUSCLE CONTRACTILITY;
HEART RATE;
HOSPITAL CARE;
HOSPITAL DISCHARGE;
HOSPITALIZATION;
HUMAN;
INTERMETHOD COMPARISON;
LENGTH OF STAY;
LONG TERM CARE;
META ANALYSIS (TOPIC);
NICOTINE REPLACEMENT THERAPY;
NOTE;
OUTPATIENT CARE;
PATIENT COMPLIANCE;
PATIENT COUNSELING;
PERSONALIZED MEDICINE;
PRESCRIPTION;
PREVALENCE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
RECURRENT DISEASE;
RELAPSE;
RISK REDUCTION;
SAMPLE SIZE;
SIDE EFFECT;
SMOKING CESSATION;
STENT THROMBOSIS;
SUDDEN DEATH;
THROMBOCYTE ACTIVATION;
TREATMENT DURATION;
VASOCONSTRICTION;
WITHDRAWAL SYNDROME;
|
EID: 84873869407
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2012.11.017 Document Type: Editorial |
Times cited : (32)
|
References (13)
|